These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23521026)

  • 1. Monoclonal antibodies in neuroinflammatory diseases.
    Klotz L; Wiendl H
    Expert Opin Biol Ther; 2013 Jun; 13(6):831-46. PubMed ID: 23521026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of antibody therapy in demyelinating diseases.
    Akaishi T; Nakashima I
    Int Immunol; 2017 Jul; 29(7):327-335. PubMed ID: 28910968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates.
    Dubey D; Kieseier BC; Hartung HP; Hemmer B; Miller-Little WA; Stuve O
    Expert Rev Clin Immunol; 2015 Jan; 11(1):93-108. PubMed ID: 25495182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
    Deiß A; Brecht I; Haarmann A; Buttmann M
    Expert Rev Neurother; 2013 Mar; 13(3):313-35. PubMed ID: 23448220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies in treatment of multiple sclerosis.
    Rommer PS; Dudesek A; Stüve O; Zettl UK
    Clin Exp Immunol; 2014 Mar; 175(3):373-84. PubMed ID: 24001305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody treatments for multiple sclerosis.
    Rose JW; Foley J; Carlson N
    Curr Neurol Neurosci Rep; 2008 Sep; 8(5):419-26. PubMed ID: 18713579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating multiple sclerosis with monoclonal antibodies.
    Buttmann M; Rieckmann P
    Expert Rev Neurother; 2008 Mar; 8(3):433-55. PubMed ID: 18345973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating multiple sclerosis with monoclonal antibodies: a 2010 update.
    Buttmann M
    Expert Rev Neurother; 2010 May; 10(5):791-809. PubMed ID: 20420497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alemtuzumab and multiple sclerosis: therapeutic application.
    Minagar A; Alexander JS; Sahraian MA; Zivadinov R
    Expert Opin Biol Ther; 2010 Mar; 10(3):421-9. PubMed ID: 20095876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New biological agents in the treatment of multiple sclerosis.
    Buc M
    Bratisl Lek Listy; 2018; 119(4):191-197. PubMed ID: 29663814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis.
    Trebst C; Voss E; Skripuletz T; Stangel M
    Curr Med Chem; 2010; 17(7):640-50. PubMed ID: 20088763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel monoclonal antibodies for therapy of multiple sclerosis.
    Knier B; Hemmer B; Korn T
    Expert Opin Biol Ther; 2014 Apr; 14(4):503-13. PubMed ID: 24579720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug insight: using monoclonal antibodies to treat multiple sclerosis.
    Hohlfeld R; Wekerle H
    Nat Clin Pract Neurol; 2005 Nov; 1(1):34-44. PubMed ID: 16932490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis - established and novel therapeutic approaches.
    Ehling R; Berger T; Reindl M
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):3-15. PubMed ID: 20236038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities and risks of the monoclonal antibody alemtuzumab as a new treatment option for multiple sclerosis].
    Warnke C; Kieseier BC; Zettl U; Hartung HP
    Nervenarzt; 2009 Apr; 80(4):468-74. PubMed ID: 19296065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
    Gasperini C; Haggiag S; Ruggieri S
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1243-53. PubMed ID: 23855792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of neuromyelitis optica].
    Nomura K
    Nihon Rinsho; 2013 May; 71(5):829-38. PubMed ID: 23777090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies for the treatment of multiple sclerosis].
    Sánchez-Seco VG; Casanova Peño I; Arroyo González R
    Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on the etiology and pathogenesis of multiple sclerosis and neuromyelitis optica].
    Fujihara K
    Nihon Rinsho; 2008 Jun; 66(6):1087-91. PubMed ID: 18540352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.